scispace - formally typeset
J

Janine Müller

Researcher at German Center for Neurodegenerative Diseases

Publications -  15
Citations -  489

Janine Müller is an academic researcher from German Center for Neurodegenerative Diseases. The author has contributed to research in topics: Stem cell & Neural stem cell. The author has an hindex of 11, co-authored 15 publications receiving 426 citations. Previous affiliations of Janine Müller include Bielefeld University.

Papers
More filters
Journal ArticleDOI

Isolation of novel multipotent neural crest-derived stem cells from adult human inferior turbinate.

TL;DR: A novel, readily accessible source of multipotent human NCSCs for potential cell-replacement therapy is described and a separation strategy based on magnetic cell sorting of p75(NTR) positive ITSCs that formed larger neurospheres and proliferated faster than p75-NTR negative ITSCs is developed.
Journal ArticleDOI

1,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity

TL;DR: A novel mode of action of 1,8-cineol through inhibition of nuclear NF-κB p65 translocation via IκBα resulting in decreased levels of proinflammatory NF-kkB target genes is suggested and may therefore broaden the field of clinical application of this natural drug for treating inflammatory diseases.
Journal ArticleDOI

Efficient animal-serum free 3D cultivation method for adult human neural crest-derived stem cell therapeutics.

TL;DR: A novel, human blood plasma based semi-solid medium for cultivation of human neural crest-derived inferior turbinate stem cells (ITSCs) within a blood plasma matrix, where they revealed higher proliferation rates compared to a standard serum-free approach.
Journal ArticleDOI

1,8-Cineole potentiates IRF3-mediated antiviral response in human stem cells and in an ex vivo model of rhinosinusitis.

TL;DR: It is demonstrated for the first time that 1,8-cineole potentiates poly(I:C)-induced activity of the antiviral transcription factor interferon regulatory factor 3 (IRF3), while simultaneously reducing proinflammatory nuclear factor (NF)-κB activity in human cell lines, inferior turbinate stem cells and in ex vivo cultivated human nasal mucosa.